|
|
|
Russian Pharma Industry In Details
5/9/2013 | published by: Euroresearch & Consulting
Russian Pharma Industry In Details
Purpose of this report was to analyze Russian of pharma.
Please pay attention:
Benefits of buying the report:
The report included large volume
|
read more...
|
$3,750.00
|
|
Hospital Construction in the US - Industry Market Research Report
5/3/2013 | published by: IBISWorld
Hospital Construction Over the next five years, the Hospital Construction industry is expected to enter into a recovery period. The implementation of the Patient Protection and Affordable Care Act will result in more than 32 million
|
read more...
|
$1,020.00
|
|
Business Strategy: Accountable Care Maturity Model
5/6/2013 | published by: IDC
This IDC Health Insights report discusses IDC Health Insights' Accountable Care Maturity Model. The relative immaturity of accountable care brings many challenges to the healthcare industry. IDC Health Insights' Accountable Care Maturity Model presents healthcare
|
read more...
|
$4,500.00
|
|
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: The risks of investing in Côte d'Ivoire's pharmaceutical and healthcare industry arenumerous. Politically, the country is in a fragile state, with concerns over security commonplace.Economically, Côte d'Ivoire posts a better performance, but there
|
read more...
|
$1,295.00
|
|
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low commitment to healthcare,combined with political and economic uncertainties, will remain
|
read more...
|
$1,295.00
|
|
Algeria Pharmaceuticals and Healthcare Report Q3 2013
5/22/2013 | published by: Business Monitor International
BMI View: Algerian authorities appear committed to healthcare development programme, the 2010-2014tranche of which envisages the construction of more than 150 new hospitals and numerous otherfacilities. This expansion of medical services will provide an impetus
|
read more...
|
$1,295.00
|
|
Taiwan Pharmaceuticals and Healthcare Report Q3 2013
5/22/2013 | published by: Business Monitor International
BMI View: Taiwan will continue to represent a modestly attractive proposition for drug manufactures. Ourview is based on factors such as the maturity of its pharmaceutical market, government encouragement ofgeneric medicines and authorities desire to
|
read more...
|
$1,295.00
|
|
Zambia Pharmaceuticals and Healthcare Report Q3 2013
5/22/2013 | published by: Business Monitor International
BMI View: Zambia has a strong economy thanks to its relative political stability and copper miningindustry, but there are considerable gaps in its provision of healthcare services. With many specialisthealthcare professionals concentrated in the capital,
|
read more...
|
$1,295.00
|
|
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
5/8/2013 | published by: Business Monitor International
BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI
|
read more...
|
$1,175.00
|
|
Australia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
BMI View: As a developed market, Australia represents opportunities for risk averse pharmaceuticalinvestors, given its ageing and generally affluent population. Importantly, the government is implementingcost-cutting measures to cope with escalating healthcare costs, therefore generic drugmakers
|
read more...
|
$1,175.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Dermatology Reports